Gram, D.X.; Fribo, J.; Nagy, I.; Gotfredsen, C.; Charrua, A.; Hansen, J.B.; Hansen, A.J.; Szallasi, A.
TRPV1 Antagonists as Novel Anti-Diabetic Agents: Regulation of Oral Glucose Tolerance and Insulin Secretion Through Reduction of Low-Grade Inflammation? Med. Sci. 2019, 7, 82.
https://doi.org/10.3390/medsci7080082
AMA Style
Gram DX, Fribo J, Nagy I, Gotfredsen C, Charrua A, Hansen JB, Hansen AJ, Szallasi A.
TRPV1 Antagonists as Novel Anti-Diabetic Agents: Regulation of Oral Glucose Tolerance and Insulin Secretion Through Reduction of Low-Grade Inflammation? Medical Sciences. 2019; 7(8):82.
https://doi.org/10.3390/medsci7080082
Chicago/Turabian Style
Gram, Dorte X., Josefine Fribo, Istvan Nagy, Carsten Gotfredsen, Ana Charrua, John B. Hansen, Anker J. Hansen, and Arpad Szallasi.
2019. "TRPV1 Antagonists as Novel Anti-Diabetic Agents: Regulation of Oral Glucose Tolerance and Insulin Secretion Through Reduction of Low-Grade Inflammation?" Medical Sciences 7, no. 8: 82.
https://doi.org/10.3390/medsci7080082
APA Style
Gram, D. X., Fribo, J., Nagy, I., Gotfredsen, C., Charrua, A., Hansen, J. B., Hansen, A. J., & Szallasi, A.
(2019). TRPV1 Antagonists as Novel Anti-Diabetic Agents: Regulation of Oral Glucose Tolerance and Insulin Secretion Through Reduction of Low-Grade Inflammation? Medical Sciences, 7(8), 82.
https://doi.org/10.3390/medsci7080082
